With the rise in geriatric population, the clinical nutrition spending is expected to increase over the coming years. Moreover, the global clinical nutrition business sector is expanding due to the high birth rate, increasing number of patients receiving malnutrition treatment, and high number of premature births across various countries. The global clinical nutrition market is expected to increase at steady rate and is likely to ascend from USD 47.67 billion in 2019 to USD 74.99 billion by 2027, at a CAGR 6.2% over the forecast period (2020-2027), according to QuantAlign Research.

High birth rate nations are expected to witness more incidents of premature birth. Premature birth leads to long-term adverse health consequences. Prematurely born children are prone to suffer from sensory deficit, cerebral palsy, learning disabilities, and respiratory illnesses compared to children born at the end of the normal term.  As per WHO, every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation), and this number is rising. Preterm birth complications are the leading cause of death among children under 5 years of age. More than 60% of premature births occur in Sub-Saharan Africa, and South Asia. The increasing number of premature births in developing countries has led to growing awareness towards the clinical nutritional products.

Browse complete report with TOC :

Global Clinical Nutrition Market Demand Outlook, COVID-19 Impact, Trend Analysis, By Category (Immuno-nutrition, Functional Foods, Endocrine nutrition, Parenteral nutrition, Enteral Nutrition), By Application, By End-User and Industry Estimates 2020-2027 –  “https://quantalignresearch.com/global-clinical-nutrition-market-report “

Key insights: 

• The infant nutrition segment held the largest share in 2019, while the parenteral nutrition segment is poised to grow at highest CAGR over the forecast period
• The pediatric segment was the largest end user of the clinical nutrition products in 2019, and would continue its dominance during the forecast period (2020- 2027)
•  Regionally, Asia-Pacific accounted for the largest market for clinical nutritional products, with a share of 35.2% of the global market share in 2019. The growth is attributed to the increasing birth rate, coupled with growing geriatric population, in the Asia-Pacific region

Key players operating in the market include: Baxter International Inc., Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira, Inc., Perrigo Company Plc, Lonza Ltd.among others.